Mid-period crossings: the quarter's story is things that started during it and are still completing
The model's full reasoning — Q1 2018 call → NOWe need to answer YES or NO based on the criteria. The question asks: "On this call, is management's account of the just-reported period built substantially around REAL BUSINESS ACTIVITY THAT CROSSED FROM NOT-HAPPENING TO HAPPENING PARTWAY THROUGH THE PERIOD OR JUST AROUND ITS EDGES — and does management make clear that this newly started activity is still completing its climb, so the period's reported numbers averaged the 'before' and 'after' and therefore sit below the level at which the business is already running?" We need to check if management describes concrete business that began during or around the period, and that the climb is incomplete, with reported numbers lagging. From the transcript, we have several mentions of new things: iSeq launched in Q1, shipped units to customers for beta testing, but they identified improvements and expect to scale shipments midyear. So iSeq is not yet fully transacting? It says "shipped units to customers for beta testing" - that's not real revenue-generating activity? It's beta testing, not paying customers. So that might not count. Other new things: The oncology collaborations with Loxo and BMS were announced, but they had no revenue impact in Q1, and milestones are in the future. So those are not yet started. What about the S1 flow cell launched at AGBT in mid-February? It says "officially launched at AGBT in mid-February has received great customer feedback, and is expected to ramp throughout 2018." So that is a product launch that began in the period. But is it generating revenue? It says "S1 flow cell which we officially launched at AGBT in mid-February has received great customer feedback, and is expected to ramp throughout 2018." That suggests it started selling, but we don't know if it's substantial. Also, the ramp is expected throughout 2018, so the climb is incomplete. But is this a central part of the period's story? The call discusses NovaSeq consumables growth, and mentions S1 as part of that. But the main story is about consumables growth across the portfolio. Another new thing: The Harvard Pilgrim study launched in Q1, but that's a study, not revenue-generating. The MiSeq study for rugged? Also a study.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AIN | Albany International Corp. | Q3 2023 | 2023-11-07 | B |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| CARS | Cars.com Inc. | Q1 2023 | 2023-05-06 | B |
| HLX | Helix Energy Solutions Group, Inc. | Q1 2018 | 2018-04-24 | B+ |
| SBSI | Southside Bancshares, Inc. | Q4 2017 | 2018-02-06 | A |
| ANIP | ANI Pharmaceuticals, Inc. | Q4 2016 | 2017-03-02 | B+ |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| ESE | ESCO Technologies Inc. | Q2 2016 | 2016-05-03 | A |
AFL · Q2 2023 → YESThe question is about whether management's account of the just-reported period is built around real business activity that started partway through the period, and that the numbers average before and a...YES The transcript shows management's account centered on the Japan Post cancer insurance launch in early April, which began selling the product and drove a 60% sales increase as a major contributor. They describe the activity as real and transacting, with Dan Amos noting the significant contribution from the new product. Yoshizumi confirms gradual increase going forward, and Fred highlights runway for more agents and sales calming down after initial jump, indicating the Q2 numbers reflect partial ramp-up rather than full run-rate.
ESE · Q2 2016 → YESThe question is about whether management's account of the just-reported period is built around real business activity that started partway through the period, and that the numbers average before and a...YES The transcript shows management's account centered on the real mid-period start of Plastique's contribution (acquired partway through Q2, with two months of performance noted and "early performance consistent with our acquisition forecast"), treated as a key new segment. It also explicitly addresses the incomplete climb, noting that the reported Q 2 numbers lag due to partial contribution and that Q3/Q4 will see fuller periods plus seasonality, with the business already running at a higher level as the ramp continues.
PSX · Q4 2016 → YESThe question is about whether management's account of the just-reported period is built substantially around real business activity that crossed from not-happening to happening partway through the per...YES The transcript shows management centering the Q4 story on the Freeport LPG Export Terminal's real start: commissioning completed smoothly, first commercial cargo shipped mid-December (partial Q4 contribution), with full-quarter costs incurred but only partial revenue, and explicit ramp to near-capacity loading in January onward.